Companies

Lupin’s Pithampur unit gets Health Canada clearance

PTI New Delhi | Updated on April 02, 2018 Published on April 02, 2018

Shares of Lupin were trading up by 3.6 per cent at Rs 762.90 on the BSE.

Lupin Ltd’s Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a review.

“Following the review, Health Canada has maintained the compliant rating for unit 2 at Pithampur (Indore) and has issued a revised ‘Establishment Licence’,” Lupin said in a BSE filing today.

In November 2017, Lupin had received a warning letter from the US Food and Drug Administration for its manufacturing facilities in Goa and Pithampur, Indore. Shares of Lupin were trading up by 3.6 per cent at Rs 762.90 on the BSE.

Published on April 02, 2018
This article is closed for comments.
Please Email the Editor